Show simple item record

dc.contributor.authorCiccarelli, Michele
dc.contributor.authorDawson, Dana
dc.contributor.authorFalcao-Pires, Inês
dc.contributor.authorGiacca, Mauro
dc.contributor.authorHamdani, Nazha
dc.contributor.authorHeymans, Stéphane
dc.contributor.authorHooghiemstra, Astrid
dc.contributor.authorLeeuwis, Annebet
dc.contributor.authorHermkens, Dorien
dc.contributor.authorTocchetti, Carlo Gabriele
dc.contributor.authorvan der Velden, Jolanda
dc.contributor.authorZacchigna, Serena
dc.contributor.authorThum, Thomas
dc.date.accessioned2021-04-06T10:34:01Z
dc.date.available2021-04-06T10:34:01Z
dc.date.issued2021-11-01
dc.identifier.citationCiccarelli , M , Dawson , D , Falcao-Pires , I , Giacca , M , Hamdani , N , Heymans , S , Hooghiemstra , A , Leeuwis , A , Hermkens , D , Tocchetti , C G , van der Velden , J , Zacchigna , S & Thum , T 2021 , ' Reciprocal organ interactions during heart failure-a position paper from the ESC working group on myocardial function ' , Cardiovascular Research , vol. 117 , no. 12 , cvab009 , pp. 2416–2433 . https://doi.org/10.1093/cvr/cvab009en
dc.identifier.issn0008-6363
dc.identifier.otherPURE: 190694407
dc.identifier.otherPURE UUID: a52f7dff-f539-4e27-b61b-e0dc87b5176b
dc.identifier.otherPubMed: 33483724
dc.identifier.urihttps://hdl.handle.net/2164/16192
dc.descriptionAcknowledgements We thank Sabine Kafert-Kasting, Hannover Medical School, who participated in the writing and technical editing of the manuscript. Conflict of interest: C.G.T. holds patents in the field of cardiovascular disease. M.G. and T.T. hold patents in the field of non-coding RNAs and therapeutic applications thereof. T.T. is the founder and shareholder of Cardior Pharmaceuticals GmbH. T.T. reports fees/support from Novo Nordisk, Takeda, Amicus Therapeutics, Böhringer Ingelheim, and Sanofi-Genzyme (outside the scope of this position paper). S.H. reports personal fees from Astra Zeneca as a consultant preclinical development, personal fees from Cellprothera, as well as grants from Pfizer outside the submitted work. All other authors have nothing to disclose. Funding This work was supported by the British Heart Foundation, in particular, BHF Project Grant No. PG/17/64/33205 (to D.D.); European Union Commission’s Seventh Framework program (GA 305507 [HOMAGE] to S.H.) and EU Horizon 2020 project CARDIOREGENIX (GA 825670 to T.T.); ERA-Net-CVD project MacroERA (01KL1706 to S.H.); IMI2-CARDIATEAM (No. 821508 to S.H.); Netherlands Cardiovascular Research Initiative—an initiative with support of the Dutch Heart Foundation (CVON2016-Early HFPEF, 2015-10; CVON She-PREDICTS, 2017-21; and CVON Arena-PRIME, 2017-18 to S.H.; CVON 2018-28 & 2012-06 Heart Brain Connection; and CVON-Dosis 2014-20 to J.v.d.V., A.H., A.L., and D.H.); Research Foundation Flanders FWO (G091018N and G0B5930N to S.H.); Deutsche Forschungsgemeinschaft (KFO311/TH903/20 to T.T.); AIRC (IG 2016 19032 to S.Z.); Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences, and the Netherlands Organization for Sciences-ZonMW (VICI 91818602 to J.v.d.V.) as well as Project NETDIAMOND (POCI-01-0145-FEDER-016385), supported by European Structural and Investment Funds, Lisbon's Regional Operational Program 2020 and national funds from the Portuguese Foundation for Science and Technology (to I. F.-P.).en
dc.format.extent18
dc.language.isoeng
dc.relation.ispartofCardiovascular Researchen
dc.rightsThe Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contactjournals.permissions@oup.comen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectHeart failureen
dc.subjectMulti-organ clinical syndromeen
dc.subjectLungen
dc.subjectIntestineen
dc.subjectKidneyen
dc.subjectBrainen
dc.subjectAdipose tissueen
dc.subjectLiveren
dc.subjectNon-coding RNAsen
dc.subjectR Medicineen
dc.subjectBritish Heart Foundationen
dc.subjectPG/17/64/33205en
dc.subjectEuropean Commissionen
dc.subject305507en
dc.subjectGA 825670en
dc.subject.lccRen
dc.titleReciprocal organ interactions during heart failure-a position paper from the ESC working group on myocardial functionen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1093/cvr/cvab009


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record